Elevance Health, Inc.
Mark Kaye (EVP & CFO) reports ELV insider transactions
About this filing
Elevance Health, Inc. (ELV) filed Form 4 (insider transaction) with the SEC on Oct 6, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Mark Kaye · EVP & CFO
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | F · tax withholdingFootnotes F1 | −4,161 | $386.43 | $1,607,935.23 | 27,876 | Direct |
| Oct 2, 2026 | A · grantFootnotes F2 | +2,627 | $0.00 | $0.00 | 30,503 | Direct |
Footnotes
- F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- F2 Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.
More ELV filings
- S-3ASR
Filed Oct 28, 2026
- 4
Filed Oct 23, 2026
- 144
Filed Oct 22, 2026
- 10-Q
Filed Oct 21, 2026
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.